World's Best Scientists 2026 revealed!
Giuseppe Pelosi

Giuseppe Pelosi

D-Index & Metrics

Medicine

D-Index
80
Citations
27716
World Ranking
16987
National Ranking
680

Overview

Giuseppe Pelosi is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, particularly focusing on pulmonary and respiratory medicine, oncology, and epidemiology. Their research includes a broad spectrum of studies related to lung cancer, neuroendocrine tumors, and medical imaging and pathology.

The scientist's recent publications include the following notable papers:

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe, 2020, Cancers
  • Morphologic and molecular classification of lung neuroendocrine neoplasms, 2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Giuseppe Pelosi collaborates frequently with a group of coauthors who have contributed to multiple works together. These include:

  • Mauro Papotti
  • Sergio Harari
  • Paul Hofman
  • Fabrizio Bianchi
  • Véronique Hofman

The main publication venues where this researcher's work appears often are:

  • Journal of Thoracic Oncology
  • Pathologica
  • Expert Review of Anticancer Therapy
  • ESMO Open
  • Cancers

In terms of their fields of study, Giuseppe Pelosi has contributed 206 publications primarily in medicine. Their specific subfields of focus include:

  • Pulmonary and Respiratory Medicine (54 publications)
  • Oncology (54 publications)
  • Epidemiology (38 publications)
  • Neurology (29 publications)
  • Molecular Biology (12 publications)

Their research topics encompass several key areas:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Medical Imaging and Pathology Studies
  • Gestational Trophoblastic Disease Studies

Best Publications

  • The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

    William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe

  • Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso

  • Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

    Gabriella Sozzi;Davide Conte;MariaElena Leon;Rosalia Cirincione

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

    Ugo Pastorino;Massimo Bellomi;Claudio Landoni;Elvio De Fiori

  • Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

    Ugo Pastorino;Marta Rossi;Valentina Rosato;Alfonso Marchianò

  • Alterations of the Notch pathway in lung cancer

    Britta Westhoff;Ivan N. Colaluca;Giovanni D'Ario;Maddalena Donzelli

  • p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.

    Justin A Bishop;Julie Teruya-Feldstein;William H Westra;Giuseppe Pelosi

  • A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancer

    Fabrizio Bianchi;Francesco Nicassio;Matteo Jacopo Marzi;Elena Belloni

  • Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Anastasios Stathis;Emanuele Zucca;Mohamed Bekradda;Carlos Gomez-Roca

  • Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables

    Giuseppe Pelosi;Enrica Bresaola;Giuseppe Bogina;Felice Pasini

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

    Andre L. Moreira;Paolo S.S. Ocampo;Yuhe Xia;Hua Zhong

  • Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Yasushi Yatabe;Sanja Dacic;Alain C. Borczuk;Arne Warth

  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.

    William D. Travis;Sanja Dacic;Ignacio Wistuba;Lynette Sholl

  • Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients.

    Giuseppe Pelosi;Jaime Rodriguez;Giuseppe Viale;Juan Rosai

  • Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

    Erik Thunnissen;Mary Beth Beasley;Alain C. Borczuk;Elisabeth Brambilla

  • A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

    Andrea Decensi;Chris Robertson;Giuseppe Viale;Francesca Pigatto

  • PD-L1 Testing for Lung Cancer in 2019 : Perspective From the IASLC Pathology Committee

    Sylvie Lantuejoul;Ming Sound-Tsao;Wendy A. Cooper;Nicolas Girard

  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Lynette M. Sholl;Fred R. Hirsch;David Hwang;Johan Botling

  • O-297 Quantification of free circulating DNA as a diagnostic marker in lung cancer

    Gabriella Sozzi;Davide Conte;Maria Elena Leon;Rosalia Cirincione

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Mauro Papotti
Mauro Papotti University of Turin
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Filippo de Braud
Filippo de Braud University of Milan
Ugo Pastorino
Ugo Pastorino University of Milan
Gabriella Sozzi
Gabriella Sozzi University of Milan
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Andrew G. Nicholson
Andrew G. Nicholson Royal Brompton Hospital
Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Yasushi Yatabe
Yasushi Yatabe Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens the door to diverse opportunities in the expanding healthcare industry. For those interested in healthcare leadership and administration, online mha programs are a flexible way to gain advanced management skills tailored to healthcare settings.

If you are looking to specialize in nutrition, an online bachelor's in nutrition allows you to study key concepts in nutritional science and dietetics—often leading to roles in wellness, health consulting, or food service management.

Nursing professionals seeking to advance their credentials may benefit from rn bsn online programs no clinicals, enabling registered nurses to earn a Bachelor of Science in Nursing entirely online, often without the need for additional on-site clinical hours.

For those aiming for the highest level of nursing practice, dnp online programs provide a pathway to a Doctor of Nursing Practice, typically with flexible and accelerated formats.

These varied online programs offer accessible routes to enter or advance within healthcare, leveraging technology for a more adaptable learning experience.

Best Scientists Citing Giuseppe Pelosi

Trending Scientists

Recently Published Articles